Industry's Responsibility For Correct Drug Use

18 November 1997

While compliance aids are helpful in getting people to use prescriptionmedicines properly, their provision should not involve expenditure by the UK National Health Service, according to Frank Dobson, UK Secretary of State for Health.

Rather, it is the responsibility of the manufacturers to get their products used correctly, said Mr Dobson, speaking at a Royal Pharmaceutical Society of Great Britain seminar this month, held to discuss a three-year joint initiative between the RPSGB and Merck Sharp & Dohme to address the issue of why patients do not take their medicines properly (Marketletter March 31).

Mr Dobson told the meeting that patients will have to be given more and better information on taking medicines. They need messages such as: "Keep taking the tablets till the bottle is empty;" - "These tablets will make you feel lousy before they make you feel well - so keep on taking them;" and "These pills should make you feel okay very quickly but they won't actually cure you until you have completed the 10-day course;" he said. "If they are never given the message, they cannot be expected to know what to do."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight